Rhinitis control and medication use in a real-world sample of patients with persistent rhinitis or rhinosinusitis : a community pharmacy study
- Author
- Sophie Scheire (UGent) , Sophie Germonpré (UGent) , Els Mehuys (UGent) , Inge Van Tongelen (UGent) , An De Sutter (UGent) , Stephane Steurbaut, Thierry Van Hees, Sophie Demarche, Lies Lahousse (UGent) , Philippe Gevaert (UGent) and Koen Boussery (UGent)
- Organization
- Abstract
- BACKGROUND: Little is known about rhinitis control in reallife, nor about the contribution of treatment-related and patientrelated factors. OBJECTIVE: This study aimed to examine the level of rhinitis control and rhinitis medication utilization in patients with persistent rhinitis and to identify predictors of rhinitis control. METHODS: A cross-sectional observational study was conducted in patients with persistent rhinitis recruited in community pharmacies. Participants completed the Rhinitis Control Assessment Test, a questionnaire on patient/rhinitis characteristics, and rhinitis medication use. A visual analog scale for nasal symptoms was also completed. Pharmacy dispensing data were used to calculate adherence to intranasal glucocorticoids. Nasal spray technique was evaluated using a standardized checklist. Predictors of rhinitis control were explored using a linear regression model. RESULTS: A total of 1,514 patients, recruited in 215 pharmacies, participated in the study (mean age 48.7 y, 62% female). Almost 60% exhibited suboptimal rhinitis control (Rhinitis Control Assessment Test pound 21 of 30). A 50-mm cut-off on the visual analog scale yielded 78.1% sensitivity to identify suboptimal rhinitis control. Participants most frequently used intranasal glucocorticoids (55.6%) and intranasal decongestants (47.4%). Only 10.3% of current nasal spray users demonstrated perfect technique. More than half (54.8%) of glucocorticoid users were identified as active asthma, and use of oral/intranasal decongestants or nasal saline were identified as predictors of worse rhinitis control. CONCLUSIONS: Suboptimal rhinitis control was common in this real-life sample of persistent rhinitis patients. Improving use of rhinitis medication may be key to increase disease con
- Keywords
- ALLERGIC RHINITIS, ASTHMA CONTROL, ADHERENCE, DISEASE, IMPACT, MANAGEMENT, DIAGNOSIS, VALIDITY, QUALITY, ADULTS
Downloads
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 1.57 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01JETQKKZ2QR9PVWVVS6MX7E24
- MLA
- Scheire, Sophie, et al. “Rhinitis Control and Medication Use in a Real-World Sample of Patients with Persistent Rhinitis or Rhinosinusitis : A Community Pharmacy Study.” JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, vol. 12, no. 7, 2024, pp. 1865-1876.e6, doi:10.1016/j.jaip.2024.04.031.
- APA
- Scheire, S., Germonpré, S., Mehuys, E., Van Tongelen, I., De Sutter, A., Steurbaut, S., … Boussery, K. (2024). Rhinitis control and medication use in a real-world sample of patients with persistent rhinitis or rhinosinusitis : a community pharmacy study. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 12(7), 1865-1876.e6. https://doi.org/10.1016/j.jaip.2024.04.031
- Chicago author-date
- Scheire, Sophie, Sophie Germonpré, Els Mehuys, Inge Van Tongelen, An De Sutter, Stephane Steurbaut, Thierry Van Hees, et al. 2024. “Rhinitis Control and Medication Use in a Real-World Sample of Patients with Persistent Rhinitis or Rhinosinusitis : A Community Pharmacy Study.” JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE 12 (7): 1865-1876.e6. https://doi.org/10.1016/j.jaip.2024.04.031.
- Chicago author-date (all authors)
- Scheire, Sophie, Sophie Germonpré, Els Mehuys, Inge Van Tongelen, An De Sutter, Stephane Steurbaut, Thierry Van Hees, Sophie Demarche, Lies Lahousse, Philippe Gevaert, and Koen Boussery. 2024. “Rhinitis Control and Medication Use in a Real-World Sample of Patients with Persistent Rhinitis or Rhinosinusitis : A Community Pharmacy Study.” JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE 12 (7): 1865-1876.e6. doi:10.1016/j.jaip.2024.04.031.
- Vancouver
- 1.Scheire S, Germonpré S, Mehuys E, Van Tongelen I, De Sutter A, Steurbaut S, et al. Rhinitis control and medication use in a real-world sample of patients with persistent rhinitis or rhinosinusitis : a community pharmacy study. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2024;12(7):1865-1876.e6.
- IEEE
- [1]S. Scheire et al., “Rhinitis control and medication use in a real-world sample of patients with persistent rhinitis or rhinosinusitis : a community pharmacy study,” JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, vol. 12, no. 7, pp. 1865-1876.e6, 2024.
@article{01JETQKKZ2QR9PVWVVS6MX7E24,
abstract = {{BACKGROUND: Little is known about rhinitis control in reallife, nor about the contribution of treatment-related and patientrelated factors. OBJECTIVE: This study aimed to examine the level of rhinitis control and rhinitis medication utilization in patients with persistent rhinitis and to identify predictors of rhinitis control. METHODS: A cross-sectional observational study was conducted in patients with persistent rhinitis recruited in community pharmacies. Participants completed the Rhinitis Control Assessment Test, a questionnaire on patient/rhinitis characteristics, and rhinitis medication use. A visual analog scale for nasal symptoms was also completed. Pharmacy dispensing data were used to calculate adherence to intranasal glucocorticoids. Nasal spray technique was evaluated using a standardized checklist. Predictors of rhinitis control were explored using a linear regression model. RESULTS: A total of 1,514 patients, recruited in 215 pharmacies, participated in the study (mean age 48.7 y, 62% female). Almost 60% exhibited suboptimal rhinitis control (Rhinitis Control Assessment Test pound 21 of 30). A 50-mm cut-off on the visual analog scale yielded 78.1% sensitivity to identify suboptimal rhinitis control. Participants most frequently used intranasal glucocorticoids (55.6%) and intranasal decongestants (47.4%). Only 10.3% of current nasal spray users demonstrated perfect technique. More than half (54.8%) of glucocorticoid users were identified as active asthma, and use of oral/intranasal decongestants or nasal saline were identified as predictors of worse rhinitis control. CONCLUSIONS: Suboptimal rhinitis control was common in this real-life sample of persistent rhinitis patients. Improving use of rhinitis medication may be key to increase disease con}},
author = {{Scheire, Sophie and Germonpré, Sophie and Mehuys, Els and Van Tongelen, Inge and De Sutter, An and Steurbaut, Stephane and Van Hees, Thierry and Demarche, Sophie and Lahousse, Lies and Gevaert, Philippe and Boussery, Koen}},
issn = {{2213-2198}},
journal = {{JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE}},
keywords = {{ALLERGIC RHINITIS,ASTHMA CONTROL,ADHERENCE,DISEASE,IMPACT,MANAGEMENT,DIAGNOSIS,VALIDITY,QUALITY,ADULTS}},
language = {{eng}},
number = {{7}},
pages = {{1865--1876.e6}},
title = {{Rhinitis control and medication use in a real-world sample of patients with persistent rhinitis or rhinosinusitis : a community pharmacy study}},
url = {{http://doi.org/10.1016/j.jaip.2024.04.031}},
volume = {{12}},
year = {{2024}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: